InsidersTradesSigma
Total declarations
Company
▲ Purchases (3 ops.)
▼ Sales (0 ops.)
Explore the complete record of transactions filed by Poradosu Enrique, Autre. Officer active across 1 company, notably Nuvectis Pharma, Inc.. Aggregated, 4 disclosures have been logged. Breakdown: 3 buys · 0 sell. Total volume traded: €28k. Activity tracked since 4 February 2022. The latest transaction was disclosed on 12 May 2022 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Declarations4 total
370 shares@ US$14.760.0018% mcap19.1% of flowCommon StockSEC:0001104659-22-060908:0
Ideal exit: 6 Feb 2023 (T+270)
60,000 shares0Common StockSEC:0001104659-22-042815:0
3,800 shares@ US$3.350.0038% mcap40.4% of flowCommon Stock, par value $0.00001SEC:0001104659-22-014376:0
Ideal exit: 1 Nov 2022 (T+270)
3,800 shares@ US$3.35100.0% of flowCommon Stock, par value $0.00001SEC:0001104659-22-014376
Ideal exit: 1 Nov 2022 (T+270)
4 of 4 declarations
About Poradosu Enrique
Poradosu Enrique is the Chief Science & Business Officer at Nuvectis Pharma, Inc. In this role, he oversees the company's scientific and business initiatives, contributing to its strategic development. His expertise is essential in aligning scientific objectives with business opportunities.
